AJG vs CORT · P/E 33, rev $8.76B vs P/E 199, rev $421.1M
Arthur J Gallagher & Co (AJG) versus Corcept Therapeutics Incorporated (CORT) — a side-by-side from cached financials, not a winner call.
Arthur J Gallagher & Co (AJG) is a insurance brokers company listed on US.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Latest reported AJG revenue for 2026-06-30 was $8.76B. Net income was $1.15B. Revenue was up 84.1% from 2026-03-31 to 2026-06-30. AJG currently screens at market cap $52.03B and trailing P/E 32.8.
Latest reported CORT revenue for 2026-06-30 was $421.1M. Net income was $11.2M. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
AJG currently screens at market cap $52.03B and trailing P/E 32.8. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Not investment advice. Open the AJG and CORT stock pages for the full models.
Not investment advice.